Cognex and Pregnancy
No clinical studies have been conducted on Cognex and pregnancy, so it is not known whether the medication is safe for pregnant women. However, since the drug is used for treating Alzheimer's disease (a disease not likely to occur in women of childbearing age), it is unlikely that a pregnant woman would need to use it. If you are taking Cognex and pregnancy occurs, let your healthcare provider know immediately.
Cognex® (tacrine hydrochloride) is a prescription medication approved to treat Alzheimer's disease. It is not known whether Cognex is safe for pregnant women.
The U.S. Food and Drug Administration (FDA) uses a pregnancy category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans but do appear to cause harm to the fetus in animal studies. Also, medicines that have not been studied in any pregnant women or animals are automatically given a pregnancy Category C rating.
Cognex was given a pregnancy Category C rating because it has not been adequately studied in any pregnant women or animals. However, a pregnancy Category C medicine may be given to pregnant women if a healthcare provider believes that the benefits to the pregnant woman outweigh any possible risks to the unborn child. It is important to note that Cognex is approved only for the treatment of Alzheimer's disease, a disease that is not likely to occur in women of childbearing age.
If you are pregnant or thinking about becoming pregnant, let your healthcare provider know. He or she will consider both the benefits and risks of taking Cognex during pregnancy before making a recommendation for your particular situation.